The thyroxine :thyroxine-binding globulin ratio in serum (T4 :TBG) has been proposed
as a measure of thyroid status unaffected by altered binding protein levels. Here 320 apparently euthyroid patients are used to derive euthyroid ranges for serum thyroxine concentrations at specific TBG levels. These ranges are compared with those predicted by a T4 :TBG reference range derived from the same patient data. The comparison suggests that the ratio would give false positives for hyperthyroidism at low TBG levels and false negatives at high TBG levels. To overcome this the use of graphical reporting of results or the relation of patient results to empirical reference ranges appropriate to the TBG level is suggested.
Burr et al. 1 suggested the use of the serum concentration ratio of thyroxine to thyroxine-binding globulin (T4:TBG). They found this superior to the free thyroxine index in correcting for abnormal binding protein levels when assessing thyroid status.! On the basis of a mathematical model, however, Roosdorp and Joustra" predicted that euthyroid ranges for T4:TBG would vary with TBG level, while Lecureuil et al. 4 found T4:TBG to be inaccurate when THG concentrations were high or low. In the present paper, the validity of the T4:TBG reference range is assessed using patients' samples. 'Apparently euthyroid' ranges for T4 concentration are derived at each of a range of TBG levels. The same data are used to derive a single 1'4 :TBG reference range, and the disagreement between the two sets of reference ranges is assessed.
Patients and methods
The study included all the thyroid function requests received in this laboratory over a four-week period. immunoassay," TBG by radial immunodiffusion" and thyrotrophin (TSH). TSH was determined by a double antibody radioimmunoassay using MRC 68/38 as working standard. Antibody (M168 3578) and TSH for labelling were obtained from the Women's Hospital, Birmingham. Three hundred and forty 'apparently euthyroid' individuals were selected from the sample by excluding all patients previously diagnosed as hyperthyroid or hypothyroid, all those treated for either condition, and all those with TSH concentration greater than 5 mUll. Samples from 40 pregnant women with no evidence of thyroid dysfunction were also analysed to give more results in the upper range of TBG levels.
Results
The distribution of TBG levels in the apparently euthyroid group is shown in Figure 1 . The mean TBG level for this group was 12·14 mg/I ± 2·24 (SD), and for all 679 patients 12·31 mgll ± 2·30 (SD).
The patients were grouped on the basis of THG level, and the mean and SD for T4 were calculated for each 1 mg/I increment in TBG between 8 and 17 rngjl, Mean and SD were also calculated for the group of pregnant women with THG in the range 20-24'9 rng/I and for the group with TBG above 25 mg/I, All means and SD were recalculated after excluding results, 20 in all, which lay outside ± 2 SD. This was done to avoid distortion of small samples by outlying results or abnormals not previously excluded.
The mean T4:TBG ratio for all 340 patients was 8· 68 ± 1.53 (SD). The correlation coefficient r = 0'617 between T4 and TBG reflects the variation introduced by factors other than TBG. Figure 2 shows the means ± 2 SD for each increment in TBG and compares these with the T4 levels corresponding to the mean ± 2 SD for T4:
TBG ratio of the whole sample. The observed mean T4 concentration for the groups of patients showed very good fit to a straight line. The regression line was T4 = 6·9 TBG + 21·4 (r = 0'998).
At TBG concentrations below 12 mg/l the observed means were higher than expected from the T4:TBG ratio, while the means above 12 mgjl were lower than predicted. The observed SDs were wider below, and narrower above, the same level of TBG.
The combination of these effects produced agreement between the observed lower limits and the lower limit for T4:TBG. The observed upper limits, however, are higher at low TBG and lower at high TBG than predicted from the ± 2 SD range for T4:TBG.
Discussion
The interpretation of any test of thyroid status involves the comparison of the result with an appropriate reference range. In the present study, the apparently euthyroid group gave ± 2 SD limits for T4 of 57-155 nmol/l. The use of the TBG assay (Fig. 2) allowed narrower reference ranges to be assigned, giving greater sensitivity to altered thyroid status. At a TBG level of 11-12 mg/I the observed range was 64-138 nmol/l, The change in observed ranges with altered TBG concentration is such that interpretation is affected at commonly encountered TBG levels. At 14 mg/I the mean T4 concentration is above the upper limit for a TBG level of 10 rng/l. In the present sample 15% of patients had TBG levels below 10 mg/l and 18% had levels above 14 rng/l. When T4 alone is used as an initial test, many of these patients give borderline results and require TSH or triiodothyronine (T3) assay to clarify their status. TBG assay reduces th =number of such assays required? and is particularly useful with T3, which is itself TBG-dependent.
The T4:TBG ratio was proposed as a measure of thyroid function independent of TBG.l The present study, however, supports the findings, based on the law of mass action," 4 that the T4 :TBG ratio varies with TBG concentration. The observed mean T4: TBG ratio of 9· 9 at a TBG level of 8· 5 mg/l fell to 8·0 at 16·5 mg/l and 7·0 above 25 mgfl.
The T4:TBG ratio represents an approximation to the dissociation equation:
TBG-bound thyroxine Free thyroxine = constant x Free TBG Total T4 concentration includes thyroxine bound to other proteins, represented by the T4 intercept at zero TBG. This makes a much larger contribution to the T4:TBG ratio at lower TBG levels, accounting for the observed discrepancy. The T4:TBG reference range suggests that not only the mean, but also the SD of the euthyroid T4 range at a given TBG level is proportional to the TBG concentration and the T4 concentration falls to zero at zero TBG. This was not found in practice.
Burr et al. 2 found the T4:TBG ratio a satisfactory index of thyroid status. The results of the present study, however, do not conflict with their data. Although they found most euthyroid individuals had T4:TBG within their confidence limits, several with low TBG levels had elevated ratios, while those with high TBG levels had ratios in the lower part of the T4:TBG range. They also reported a mean T4 concentration at zero TBG to be close to the intercept found here.
While all their patients with confirmed hyperthyroidism had raised T4:TBG ratios, none had TBG levels above 18 mg/l, where misclassification is most likely. Those with low TBG levels had T4 concentrations which were also above the euthyroid ranges presented here. The good discrimination between hypothyroid and euthyroid status reported by Burr et al. is consistent with the agreement found in this study between the lower T4 :TBG limit and the observed lower limits for T4.
The T4:TBG ratio is convenient for reporting purposes as a single numerical value, and reference ranges are involved. The above findings, however, suggest that although accurate in differentiating hypothyroidism from euthyroidism, and euthyroidism with raised TBG from hyperthyroidism with normal TBG, the ratio gives false positives for thyrotoxicosis at low TBG levels and false negatives at high TBG levels. The latter is particularly important in the diagnosis and treatment of thyroid disease in pregnancy.
The resolution of these problems leads to loss of simplicity of reporting. A T4:TBG ratio corrected for the non-zero intercept would still give inaccurate upper and lower T4 limits. Roosdorp and Joustra" advocated graphical reporting using two-dimensional maps, while Lecureuil et al;" suggested using T4 and TBG to compute a free thyroxine concentration. An alternative form of numerical report, which could easily be extended to T3, is simply to report the observed T4 and TBG levels, together with the T4 reference range for that TBG level.
Indices of free thyroxine concentration have generally been assessed by defining confidence limits from a normal population and then showing that euthyroid individuals and patients with confirmed abnormal function are correctly classified. Since patients with TBG levels close to the mean will predominate, these will be given more weight in calculating confidence limits and provide most of those with abnormal function. The critical patients in confirming accurate classification, those with both abnormal TBG levels and abnormal function and with results close to the confidence limits, are very rare.
The method employed in the present paper of examining the euthyroid range of the parameter at each TBG level uses more readily available clinical material and is sensitive to small deviations from expected behaviour. It could be applied to the comparison of the wide range of T3 uptake tests and commercial free thyroxine assays now available. Some of the latter, such as Immophase Free T4 (Corning Medical, Halstead, Essex) and Gammacoat (Travenol Laboratories, Thetford, Norfolk), rely on assumptions implicit in the methods. The approach in this paper could be used to assess whether results in practice are independent of the TBG concentration.
